Literature DB >> 17498271

Nomenclature of prominin-1 (CD133) splice variants - an update.

C A Fargeas1, W B Huttner, D Corbeil.   

Abstract

Prominin-1 (CD133), a pentaspan membrane glycoprotein that constitutes an important cell surface marker of various, either normal or cancerous, stem cell populations is widely used to isolate or characterize such cells in different systems. Occurring throughout the metazoan evolution with a remarkably conserved genomic organization, it may be expressed as different splice variants with distinctive characteristics. A rational nomenclature has been proposed earlier for their consistent designation across species. Although generally accepted, it seems to be misunderstood in view of the recent report of novel prominin-1 complementary DNAs in rhesus monkey and humans with improper naming. As this may lead to confusion, we have reexamined the genomic organization of prominin-1 in various primates to provide an update that should further clarify the rationale of the nomenclature for prominin-1 gene products. This report comprises (i) the determination of the genomic organization of prominin-1 gene in two non-human primates, i.e. Macaca mulatta and Pan troglodytes, commonly used in research, (ii) the mapping of a new exon that creates an alternative cytoplasmic C-terminal end of prominin-1, (iii) the identification of various potential PDZ-binding domains generated by alternative cytoplasmic C-terminal tails, suggesting that different prominin-1 splice variants might interact with distinct protein partners, and (iv) a summing up of the different prominin-1 splice variants.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17498271     DOI: 10.1111/j.1399-0039.2007.00825.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  38 in total

1.  Prominin-2 is a novel marker of distal tubules and collecting ducts of the human and murine kidney.

Authors:  József Jászai; Lilla M Farkas; Christine A Fargeas; Peggy Janich; Michael Haase; Wieland B Huttner; Denis Corbeil
Journal:  Histochem Cell Biol       Date:  2010-03-24       Impact factor: 4.304

2.  The identification of a novel antibody for CD133 using human antibody phage display.

Authors:  Paige M Glumac; Colleen L Forster; Hong Zhou; Paari Murugan; Shilpa Gupta; Aaron M LeBeau
Journal:  Prostate       Date:  2018-05-22       Impact factor: 4.104

3.  Co-Expression of Putative Cancer Stem Cell Markers CD44 and CD133 in Prostate Carcinomas.

Authors:  Elham Kalantari; Mojgan Asgari; Seyedehmoozhan Nikpanah; Naghme Salarieh; Mohammad Hossein Asadi Lari; Zahra Madjd
Journal:  Pathol Oncol Res       Date:  2017-01-12       Impact factor: 3.201

4.  Prominin-1 (CD133, AC133) and dipeptidyl-peptidase IV (CD26) are indicators of infinitive growth in colon cancer cells.

Authors:  Thomas W Grunt; Alexandra Hebar; Sylvia Laffer; Renate Wagner; Barbara Peter; Harald Herrmann; Alexandra Graf; Martin Bilban; Martin Posch; Gregor Hoermann; Matthias Mayerhofer; Gregor Eisenwort; Christoph C Zielinski; Edgar Selzer; Peter Valent
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

5.  Activation of D2 Dopamine Receptors in CD133+ve Cancer Stem Cells in Non-small Cell Lung Carcinoma Inhibits Proliferation, Clonogenic Ability, and Invasiveness of These Cells.

Authors:  Soumyabrata Roy; Kai Lu; Mukti Kant Nayak; Avishek Bhuniya; Tithi Ghosh; Suman Kundu; Sarbari Ghosh; Rathindranath Baral; Partha Sarathi Dasgupta; Sujit Basu
Journal:  J Biol Chem       Date:  2016-12-05       Impact factor: 5.157

6.  Inconsistent immunohistochemical expression patterns of four different CD133 antibody clones in glioblastoma.

Authors:  Simon K Hermansen; Karina G Christensen; Stine S Jensen; Bjarne W Kristensen
Journal:  J Histochem Cytochem       Date:  2011-04       Impact factor: 2.479

7.  Beta4 tubulin identifies a primitive cell source for oligodendrocytes in the mammalian brain.

Authors:  Chuanshen Wu; Ansi Chang; Maria C Smith; Roy Won; Xinghua Yin; Susan M Staugaitis; Dimitri Agamanolis; Grahame J Kidd; Robert H Miller; Bruce D Trapp
Journal:  J Neurosci       Date:  2009-06-17       Impact factor: 6.167

8.  Robust expression of Prominin-2 all along the adult male reproductive system and urinary bladder.

Authors:  József Jászai; Christine A Fargeas; Michael Haase; Lilla M Farkas; Wieland B Huttner; Denis Corbeil
Journal:  Histochem Cell Biol       Date:  2008-06-07       Impact factor: 4.304

Review 9.  Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies.

Authors:  Per Ø Sakariassen; Heike Immervoll; Martha Chekenya
Journal:  Neoplasia       Date:  2007-11       Impact factor: 5.715

10.  Cone-rod dystrophy and a frameshift mutation in the PROM1 gene.

Authors:  Eran Pras; Almogit Abu; Ygal Rotenstreich; Isaac Avni; Orit Reish; Yair Morad; Haike Reznik-Wolf; Elon Pras
Journal:  Mol Vis       Date:  2009-08-28       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.